VRDN · Company research
Viridian Therapeutics, Inc. Common Stock (VRDN): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 18.22 | $2,157,142,659.48 | 1992156659.480 | — | — | — | 7595.5727446478873239 | 3.2580462673596165 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.